OncoTargets and Therapy
Volume 7, 2014 - Issue
Open access
97
Views
6
CrossRef citations to date
0
Altmetric
Original Research
Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence-free survival in patients with prostate cancer
Guo-qiang Qin1 Central Hospital of Panyu District, Guangzhou, People’s Republic of China;2 Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
, Hui-chan He2 Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
, Zhao-dong Han2 Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
, Yu-xiang Liang2 Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
, Sheng-bang Yang2 Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
, Ya-qiang Huang2 Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
, Liang Zhou2 Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
, Hao Fu2 Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
, Jie-xian Li1 Central Hospital of Panyu District, Guangzhou, People’s Republic of China;2 Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
, Fu-neng Jiang2 Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China
& Wei-de Zhong2 Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People’s Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China;3 Guangdong Provincial Institute of Nephrology, Southern Medical University, Guangzhou, People’s Republic of China;4 Urology Key Laboratory of Guangdong Province, Guangzhou Medical University, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]
show all
Pages 137-146
|
Published online: 24 Jan 2014
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.